Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

T cell receptor richness in peripheral blood increases after cetuximab therapy and correlates with therapeutic response.

Kansy BA, Shayan G, Jie HB, Gibson SP, Lei YL, Brandau S, Lang S, Schmitt NC, Ding F, Lin Y, Ferris RL.

Oncoimmunology. 2018 Aug 24;7(11):e1494112. doi: 10.1080/2162402X.2018.1494112. eCollection 2018.

2.

PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients.

Concha-Benavente F, Kansy B, Moskovitz J, Moy J, Chandran U, Ferris RL.

Cancer Immunol Res. 2018 Dec;6(12):1548-1560. doi: 10.1158/2326-6066.CIR-18-0062. Epub 2018 Oct 3.

PMID:
30282672
3.

[Immunotherapy - The New Era of Oncology].

Kansy B, Lang S.

Laryngorhinootologie. 2018 Mar;97(S 01):S3-S47. doi: 10.1055/s-0043-121594. Epub 2018 Mar 22. English, German.

4.

Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals.

Shayan G, Kansy BA, Gibson SP, Srivastava RM, Bryan JK, Bauman JE, Ohr J, Kim S, Duvvuri U, Clump DA, Heron DE, Johnson JT, Hershberg RM, Ferris RL.

Clin Cancer Res. 2018 Jan 1;24(1):62-72. doi: 10.1158/1078-0432.CCR-17-0357. Epub 2017 Oct 23.

5.

PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer.

Kansy BA, Concha-Benavente F, Srivastava RM, Jie HB, Shayan G, Lei Y, Moskovitz J, Moy J, Li J, Brandau S, Lang S, Schmitt NC, Freeman GJ, Gooding WE, Clump DA, Ferris RL.

Cancer Res. 2017 Nov 15;77(22):6353-6364. doi: 10.1158/0008-5472.CAN-16-3167. Epub 2017 Sep 13.

6.

[Extracranial schwannomas of the Head and Neck: Clinical -approach based on 20 cases].

Höing B, Stuck BA, Kansy B, Hussain T, Schlüter A, Holtmann L, Ringelstein A, Mattheis S, Lang S, Dominas N.

Laryngorhinootologie. 2017 Sep;96(9):607-614. doi: 10.1055/s-0043-110860. Epub 2017 Jul 6. German.

PMID:
28683511
7.

TORS in HPV-Positive Tumors-The New Standard?

Lang S, Mattheis S, Kansy B.

Recent Results Cancer Res. 2017;206:207-218. Review.

PMID:
27699541
8.

Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma.

Schuler PJ, Westerkamp AM, Kansy BA, Bruderek K, Dissmann PA, Dumitru CA, Lang S, Jackson EK, Brandau S.

Immunobiology. 2017 Jan;222(1):66-74. doi: 10.1016/j.imbio.2016.01.013. Epub 2016 Jan 30.

PMID:
26898925
9.

EGFR-targeted mAb therapy modulates autophagy in head and neck squamous cell carcinoma through NLRX1-TUFM protein complex.

Lei Y, Kansy BA, Li J, Cong L, Liu Y, Trivedi S, Wen H, Ting JP, Ouyang H, Ferris RL.

Oncogene. 2016 Sep 8;35(36):4698-707. doi: 10.1038/onc.2016.11. Epub 2016 Feb 15.

10.

[Immunotherapy in head and neck cancer].

Kansy B, Hussain T, Mattheis S, Wollenberg B, Brandau S, Lang S.

HNO. 2015 Nov;63(11):797-803. doi: 10.1007/s00106-015-0076-8. Review. German.

PMID:
26452491
11.

[Advances in transoral robotic surgery].

Mattheis S, Kansy B, Haßkamp P, Holtmann L, Lang S.

HNO. 2015 Nov;63(11):752-7. doi: 10.1007/s00106-015-0073-y. German.

PMID:
26449670
12.

Cervical lymph node diseases in children.

Lang S, Kansy B.

GMS Curr Top Otorhinolaryngol Head Neck Surg. 2014 Dec 1;13:Doc08. doi: 10.3205/cto000111. eCollection 2014. Review.

13.

The bidirectional tumor--mesenchymal stromal cell interaction promotes the progression of head and neck cancer.

Kansy BA, Dißmann PA, Hemeda H, Bruderek K, Westerkamp AM, Jagalski V, Schuler P, Kansy K, Lang S, Dumitru CA, Brandau S.

Stem Cell Res Ther. 2014 Aug 12;5(4):95. doi: 10.1186/scrt484.

14.

[Diseases of the cervical lymph nodes in childhood].

Lang S, Kansy B.

Laryngorhinootologie. 2014 Mar;93 Suppl 1:S49-69. doi: 10.1055/s-0033-1363218. Epub 2014 Apr 7. Review. German.

PMID:
24710787

Supplemental Content

Support Center